|
시장보고서
상품코드
1936706
인공 타액 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Artificial Saliva Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
인공 타액 시장 규모는 2025년 11억 2,000만 달러에서 2026-2034년에 CAGR 14.64%로 성장하며, 2034년에는 38억 2,000만 달러에 달할 것으로 예측됩니다.
인공타액 시장은 구강건조증(구강건조증) 유병률 증가를 주요 요인으로 하여 괄목할 만한 성장이 예상됩니다. 구강건조증은 약물, 치료, 기저질환 등 다양한 요인에 의해 유발될 수 있습니다. 구강 위생과 전신 건강에 미치는 영향에 대한 인식이 높아지면서 효과적인 인공 타액 제품에 대한 수요가 급증하고 있습니다. 제형 기술 및 전달 시스템의 혁신으로 이들 제품의 효능이 향상되어 구강건조증 환자들의 증상 완화 및 삶의 질 향상에 기여하고 있습니다. 시장에서는 천연 타액을 모방하여 윤활 작용뿐만 아니라 항균성, 구강 건강 증진에 기여하는 성분을 함유한 보다 진보된 제제로의 전환이 진행되고 있습니다.
또한 고령화 사회는 인공 타액 시장의 주요 촉진요인입니다. 노년층은 노화에 따른 요인이나 여러 약물 사용으로 인해 구강건조증을 경험할 가능성이 높기 때문입니다. 헬스케어와 만성질환 관리에 대한 관심이 높아지면서 검진 및 진단에 대한 관심이 높아져 시장 성장에 박차를 가하고 있습니다. 또한 스프레이, 젤, 마름모꼴 등 제품 투여 방법의 발전으로 인공 타액은 보다 쉽게 구할 수 있고 사용하기 쉬워졌으며, 환자의 다양한 요구에 부응할 수 있게 되었습니다.
또한 E-Commerce와 온라인 의료 플랫폼의 등장으로 인공 타액 제품에 대한 접근성이 확대되어 소비자들이 이러한 솔루션을 편리하게 구매할 수 있게 되었습니다. 환자 교육과 자기 관리에 대한 관심이 높아짐에 따라 개인이 스스로 구강 건강을 관리할 수 있게 되었고, 이는 치료 결과의 향상과 의료비 절감으로 이어지고 있습니다. 요약하면, 인공 타액 시장은 혁신, 구강 건강에 대한 인식 개선, 구강건조증으로 고통받는 개인의 삶의 질을 향상시키기 위한 노력으로 인해 견고한 성장이 예상됩니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 인공 타액 시장 : 제품별
제5장 세계의 인공 타액 시장 : 최종사용자별
제6장 세계의 인공 타액 시장 : 유통 채널별
제7장 세계의 인공 타액 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSA 26.03.19The Artificial Saliva Market size is expected to reach USD 3.82 Billion in 2034 from USD 1.12 Billion (2025) growing at a CAGR of 14.64% during 2026-2034.
The artificial saliva market is poised for significant growth, driven by the increasing prevalence of dry mouth conditions, also known as xerostomia, which can result from various factors, including medications, medical treatments, and underlying health issues. As awareness of oral health and its impact on overall well-being rises, the demand for effective artificial saliva products is surging. Innovations in formulation and delivery systems are enhancing the efficacy of these products, providing relief to individuals suffering from dry mouth and improving their quality of life. The market is witnessing a shift towards more sophisticated formulations that mimic natural saliva, incorporating ingredients that not only lubricate but also provide antimicrobial properties and promote oral health.
Moreover, the aging population is a key driver of the artificial saliva market, as older adults are more likely to experience dry mouth due to age-related factors and the use of multiple medications. The growing emphasis on preventive healthcare and the management of chronic conditions are leading to increased screening and diagnostic efforts, further propelling market growth. Additionally, advancements in product delivery methods, such as sprays, gels, and lozenges, are making artificial saliva more accessible and user-friendly, catering to the diverse needs of patients.
Furthermore, the rise of e-commerce and online health platforms is facilitating greater access to artificial saliva products, allowing consumers to purchase these solutions conveniently. The increasing focus on patient education and self-management is empowering individuals to take control of their oral health, leading to improved outcomes and reduced healthcare costs. In summary, the artificial saliva market is set for robust growth, characterized by innovation, increased awareness of oral health, and a commitment to enhancing the quality of life for individuals suffering from dry mouth conditions.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Oral Spray
- Oral Solution
- Oral Liquid
- Dissolving Tablets
- Gel
- Powder
By End-Users
- Adult
- Pediatric
By Distributional Channel
- Supermarkets
- Hypermarkets
- Others
COMPANIES PROFILED
- Cipla Inc, Mission Pharmacal Company, Fresenius Kabi AG, Parnell Pharmaceuticals Inc, Forward Science, Laboratorios KIN SA, ICPA Health Products Ltd, Nanochemazone, Lee BioSolutions, Livealth, GSK Plc, CCMed Group, Entod International, Midatech Pharma Plc, Valeant Pharmaceuticals International Inc
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL ARTIFICIAL SALIVA MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Oral Spray Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Oral Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Oral Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Dissolving Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.6. Gel Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.7. Powder Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL ARTIFICIAL SALIVA MARKET: BY END-USERS 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast End-users
- 5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL ARTIFICIAL SALIVA MARKET: BY DISTRIBUTIONAL CHANNEL 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Distributional Channel
- 6.2. Supermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL ARTIFICIAL SALIVA MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product
- 7.2.2 By End-users
- 7.2.3 By Distributional Channel
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product
- 7.3.2 By End-users
- 7.3.3 By Distributional Channel
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product
- 7.4.2 By End-users
- 7.4.3 By Distributional Channel
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product
- 7.5.2 By End-users
- 7.5.3 By Distributional Channel
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product
- 7.6.2 By End-users
- 7.6.3 By Distributional Channel
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL ARTIFICIAL SALIVA INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Cipla Inc
- 9.2.2 Mission Pharmacal Company
- 9.2.3 Fresenius Kabi AG
- 9.2.4 Parnell Pharmaceuticals Inc
- 9.2.5 Forward Science
- 9.2.6 Laboratorios KIN S.A
- 9.2.7 ICPA Health Products Ltd
- 9.2.8 Nanochemazone
- 9.2.9 Lee BioSolutions
- 9.2.10 Livealth
- 9.2.11 GSK Plc
- 9.2.12 CCMed Group
- 9.2.13 Entod International
- 9.2.14 Midatech Pharma Plc
- 9.2.15 Valeant Pharmaceuticals International Inc
